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Introduction
Several years ago at the annual meeting of the American
Pediatric Surgical Association, I was privileged to give the
Presidential Address. Since my presidency started in the old
and ended in the new century, I thought it would be appro-
priate to speak about the history of paediatric surgery in the
context of the social, medical and surgical milieux of the times.
I learned a great deal during the preparation of that lecture and
I thought it might be interesting to go into a little more detail
about some of the medical advances. I have chosen a few that
have depended on a close working relationship between phy-
sicians and scientists and engineers. They all represent major
advances in the care of patients over the past 100 plus years.
Take a deep breath
The first advance I would like to talk about is the treatment of
the respiratory form of polio. In 1916, there was a huge polio
epidemic in New York City. Some 9,000 cases were recorded,
almost one-third of them fatal; 85% of the victims were less
than 5 years old. Because of the massive immigration taking
place, the epidemic was blamed on the living conditions of
certain ethnic groups who crowded the slums of New York
City, though it was ignored that polio attacked those in both
high and low socioeconomic groups.
In 1921, the future President of the U.S.A., Franklin Delano
Roosevelt, contracted polio himself. Although he carefully
concealed his disability all of his life, it became public know-
ledge, and the polio victim was no longer a social pariah. He
established the centre for the treatment of polio in Warm
Springs, Georgia, and was photographed with the first “Poster
Child”.
In 1921, a chemical engineer, Philip Drinker, was appointed
to Harvard Medical School to study fume and dust concentra-
tions in an effort to render the industrial worker in the chemi-
cal and coal industries safer. At the same time, Philip’s brother,
Cecil, and a young physiologist named Louis Shaw were study-
ing cat respiration at the same school. They anaesthetized and
paralysed cats and were able to keep them ventilated for several
hours in a negative-pressure box that they devised. The polio
epidemics continued each summer, and the Drinker brothers
and Shaw developed an adult respirator to try to extend the cat
experiments to the polio victims who died from respiratory
failure. For $500, they had a local tinsmith make a tank,
attached to it two vacuum cleaners, and made a rubber collar
for one end. The first three experiments were conducted on
themselves. They used a mechanic’s slide for under-car work
to pull themselves into the tank. Drinker hyperventilated
himself and supposedly did not breathe for 15 minutes after
disconnecting from the device.
Dr. Charles McKhan was a paediatrician born into a medi-
cal family. He developed a strong interest in bacteriology and
infectious diseases. He moved to Harvard Medical School and
Children’s Hospital where he became familiar both with the
tragedies of polio and also with the work of Phil Drinker. In
1928, he and Drinker ventilated an 8-year-old girl with polio
who was unconscious from anoxia. She revived and asked
for ice-cream. This child died, but the proof of principle was
established. The next patient survived. From that time, hun-
dreds of “iron lungs” were built and used all over the country,
the demand far outstripping the supply. Whole rooms were
filled with patients. In the older models, there was a vacuum
cleaner on the top. Smaller patients were put end-to-end and
ventilated together or in a tiered arrangement with four chil-
dren to a tank. Rancho Los Amigos, a rehabilitation hospital
in Los Angeles, was a huge centre that still has old rusty iron
lungs in its basement.
From 1928 to 1953, hundreds and probably thousands of
patients were ventilated and saved by the iron lung. In the early
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The first patient, a woman with severe aortic insufficiency,
underwent surgery on 11 September 1952. Hufnagel sewed the
valve into her descending aorta and she lived for many years
after, with her symptoms much improved. Whenever she
opened her mouth, the ball could be heard clicking back and
forth in her descending aorta, allowing Hufnagel to hear
over the phone whether the Plexiglas valve was functioning
properly. He developed a relationship with Rudolph Schulte
of the Hyer Schulte Company in Santa Barbara, California.
Schulte was the maker of the early ventricular shunts for
hydrocephalus. Hufnagel would sketch the valve he needed;
his technician would drive out to the airport and place the
sketch in the hands of a stewardess, who would then be met
at the other end by a representative from the company. Within
the next 2 days, the valve would be made in Santa Barbara and
shipped back by the same means to Hufnagel, who would then
place it into a patient. Of the first 10 patients who received his
descending aortic valve, only one died as a consequence of the
surgery itself.
Hufnagel didn’t stop with this valve. He also developed
grafts with cloth made from mesh curtains lined with felt,
which Mrs. Hufnagel sewed together. The materials were
bought from a discount fabric store still in existence today.
He developed a disk valve to replace the diseased mitral valve.
Being an avid deep-sea fisherman, he used fishhooks to seat
the valve. The president of the fishhook company was in-
trigued and made miniature fishhooks for the valve. Her name
and the company has not survived in recorded memory.
I was Hufnagel’s first resident after he became Chairman at
Georgetown in 1969. I was privileged to watch a master sur-
geon at work, a man with extraordinary small hands and a
very big heart, and a brilliant mind that shunned publicity and
the histrionics of some of the cardiac surgeons of the day, but
a true pioneer.
Cat call
Five years before the dawning of the 20th century, a German
experimental physicist named Roentgen was working in his
laboratory investigating the properties of cathode rays. He
was playing with a cardboard screen coated with barium
platinocyanide, a material used frequently to develop photo-
graphic plates, and it lay a few feet away from the tubes that he
was using to generate electric current. He saw that the card-
board was glowing and realized he had discovered some kind
of rays, previously undescribed. One of the first pictures he
took was of his wife’s hand, which required at least a 15-
1950s, I myself developed a curious paralysis of my neck such
that I could not raise my head. I can remember many whis-
pered frightened conversations between my parents and the
local doctor, and the presumption was that I had a form of
polio, fortunately very mild.
Although the iron lung is now nothing more than a
curiosity, it led to the whole concept of artificial ventilation. I
had the privilege of talking about Phil Drinker with his son,
a respected chemical engineer in his own right. The sons of
Drinker and McKhan published a fascinating paper in JAMA
in 1986 describing the history of the iron lung.
The grind
Another very significant early development that depended on
a relationship, this time between a surgeon and a manufac-
turer, is the treatment of aortic insufficiency. Charles Anthony
Hufnagel was born in 1916. He was the son of a general
practitioner and after the early death of his father for a while
he took over his father’s practice, having graduated from
Harvard Medical School in 1941. Later, during his surgical
residency at the Peter Bent-Brigham Hospital in Boston, he
contracted tuberculosis and was told by a mentor with a very
cruel streak that because of his disease, he would never make
it as a surgeon. Hufnagel spent the rest of his life trying to
prove this person wrong and I’m not sure he ever did to his own
satisfaction. He was a brilliant experimenter who worked with
Robert Gross in freeze-drying arteries, but at Harvard Medical
School he was completely overshadowed by Gross.
When Robert Coffey, the new Chair of Surgery at
Georgetown University, was looking for a surgeon to establish
a research laboratory, Carl Walter suggested Hufnagel. He
arrived there in 1950. At that time, rheumatic fever was rife,
and stenotic and leaky cardiac valves were extremely common.
Before the heart–lung machine was developed, only closed
operations could be done, and there was no treatment for
valvular insufficiency. Hufnagel established a laboratory at
Georgetown and developed an interesting valve to replace
the function of the refluxing aortic valve. One of Hufnagel’s
interests was in ceramics and he carved the family Christmas
crèche. He was also an accomplished lapidary who polished
gems and made jewellery by hand. Perhaps it was these skills
that led him to develop and make the prototype valve, pos-
sibly using the gem-polishing equipment from his home. The
outside was made of Lucite and the ball was made of Plexiglas.
Since there was no way to operate on the open heart, he placed
these valves in the descending aorta of dogs and they worked.
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tient with huge doses of radiation and multiple blurred images.
He believed that if he could do multiple scans faster and mea-
sure mathematically the absorption of x-rays when they were
passed through the body, he could develop what would appear
to be a three-dimensional image. EMI realized that this would
be a rather expensive proposition and they did not want to use
all of their Beatles money to produce something that might
not have a market, so they sent Hounsfield to the National
Health Service. There, he suggested that his device would be
useful in detecting tiny tumours and could be used for mass
screening. England has never been very good at mass screening
for anything and the health officer was unexcited by his pro-
posal. However, when Hounsfield changed his approach and
suggested that the machine could probably see inside the
brain, the officer put Hounsfield in touch with a neuroradio-
logist, James Bull, and a neurosurgeon, James Ambrose. These
two physicians worked closely with Hounsfield, experiment-
ing on human brains provided by the Neurologic Institute in
London. On 1st October 1971, Ambrose and Hounsfield
scanned their first patient, a 41-year-old woman who had
frontal lobe symptoms suggesting a brain tumour. Her head
was suspended between water-filled boxes and a collimated
beam of x-rays was sent to her head while the instrument was
rotated 180° , degree by degree. A total of 28,000 readings
were recorded over a 4-minute period, a computer processed
them and the first CT scan confirmed a tumour in the frontal
lobe.
The first CT scanners were called EMI scanners and cost
$300,000 each. It was now possible to see the entire body and
subsequent generations of CT scanners showed bone and soft
tissues more and more clearly. EMI continued to put its major
focus on the recording of music with the CT scanner as a side
issue. Not surprisingly, they were outstripped by Siemens and
then by GE and eventually left the business.
The first EMI scanners had both x-ray collimator and
detectors rotating around the patient’s head, which created
some interesting artifacts. By the fourth generation of machine,
there were multiple detectors all the way around the head and
body and the only thing that had to move was the x-ray source.
This avoided the early distortions. CT scanners have gone
on to even greater things. In 1989, the first spiral CT entered
the market. Now everyone has a spiral CT and the latest is a
combination of CT scanner and PET scanner, which can
simultaneously show images of the various organs along
with their superimposed function. And what happened to
Hounsfield?  He won the Nobel Prize, remained with EMI, and
subsequently began developing neural networks and simu-
minute exposure. He did not really grasp the significance of
his discovery and it was only interesting to him in the sense
that he wanted to know the nature of these new x-rays that he
had produced. However, his discovery became public and the
world went wild. Roentgen had no wish to become a public
figure and even when he won the first Nobel Prize in 1901,
he returned the money and buried himself in his laboratory.
No self-respecting scientist would collaborate with a physi-
cian in the early 20th century and God forbid he should
personally profit from a scientific discovery. In the 1960s,
when the computer was developed to a fairly advanced degree,
scientists began to make the connection between the compu-
ter and x-ray images. Several scientists worked with computers
and rotating x-rays but none made a credible connection
between medicine and mathematics, and so the experiments
went no further.
Now we come to the hero of my third anecdote. A musical
instrument company known as Electronic Musical Instru-
ments Limited, or EMI, was started as a small factory building
electronic musical instruments and in the 1960s, the company
employed a brilliant man by the name of Godfrey Hounsfield.
Mr. Hounsfield had grown up in Nottinghamshire and he
was bored in school, so he didn’t do particularly well. British
schools did not recognize or pay attention to brilliant eccen-
trics such as Winston Churchill or Godfrey Hounsfield. He
volunteered for the Royal Air Force with the outbreak of
World War II in 1939 and worked on the development of
radar technology. After the war, he took a technical training
course in polytechnics and, immediately after graduation in
1951, joined EMI. EMI came to public light and interest in the
1960s when the Beatles chose this company to record their
songs. The title of this section is that of a Beatles song. EMI
made a lot of money from the Beatles and so they encouraged
Hounsfield to pursue his own field of research with little
restriction other than that he work on something that would
ultimately make more money for the company. The primary
mission of the company was to record and play back
information, i.e. music, but Hounsfield was interested in a
broader exploration of pattern recognition. He reasoned that
if many measurements could be made through an object at
various angles, the information provided could be used to
construct mathematical algorithms to reproduce the image.
He knew that this meant dealing with thousands of math-
ematical equations but, in the light of the recent developments
in computers and his own computerized brain, this was not a
formidable exercise for him. He was also aware of classical
tomography, the technique of x-raying slices through a pa-
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lations of evolution. He described the CT scanner as “the most
interesting part of my life”. He died in September 2004.
Do not fold, staple or mutilate (a caution on
government forms)
In the mid 19th century, operating in the abdomen was a very
dangerous process. In spite of the introduction of anaesthesia,
surgery was performed very quickly, often with great blood
loss and with poor suture materials. Operating on the intes-
tine was particularly dangerous because opening it made a
nonsterile environment even worse. Nonetheless, in the mid-
dle of the century, a number of fairly ingenious devices were
used to produce intestinal anastomoses. Probably many of
these leaked and the procedure fell into disuse until the last
part of the century, when John B. Murphy of Chicago, an
early Fellow of the American College of Surgeons, developed
what came to be known as the Murphy button. Two metal
pieces were used to crimp the two ends of the intestine together.
Once healing was complete, the button fell into the bowel
lumen and was passed per rectum.
The first true mechanical suture apparatus was invented
by a Budapest surgeon by the name of Hurltl. The Russian
revolutionary war caused everything in the eastern part of
Europe and Russia itself to be eventually hidden behind what
came to be known as the Iron Curtain, but in 1958, Mark
Ravitch, a brilliant forward-thinking surgeon, visited several
surgical institutes in Russia. He first went to Kiev where he
met Dr. Amosov, who performed pneumonectomies, lobecto-
mies and wedge resections of the lungs with great efficiency
and speed using staplers. Ravitch also learned from Professor
Andrasov in Moscow. Being fluent in Russian, he got into a
conversation in a café in Leningrad with a university student
who told him that the stapling instruments were made in a
Red Guard factory outside Leningrad. Ravitch remembered
that he’d seen a surgical instruments store there. To his surprise,
the Russian shopkeeper sold him a bronchial stapler that
he brought back to the U.S.A. and began to use with great
success in the dog laboratory. Sometime later, the Russians
paid him a return visit and brought with them other instru-
ments, including the prototype of the GIA (gastrointestinal
anastomosis) stapler. He was not wildly enthusiastic about the
use of staplers becoming widespread since they were heavy and
awkward, and he felt that lighter and disposable instruments
were needed. Of multiple manufacturers of instruments, only
US Surgical was interested and, with Drs. Ravitch and Steichen,
they developed the GIA, the EEA (end-to-end anastomosis),
and many other types of staplers. Since Ravitch is no longer
alive, the name of the person at US Surgical he worked with is
lost. For a long time, staplers were non-disposable, and many
of the early oesophageal replacements that I performed were
done with a GIA stapler that, far from being cumbersome and
big, I found to be light with more delicate jaws though a little
shorter than the disposable one that replaced it. All the older
models were gradually replaced by disposable ones with dif-
ferent sizes of staples and much more reliable performance.
As with any modern instruments, the goals of staplers are to
reduce time and increase the efficiency of bowel anastomoses.
There is no increased incidence of anastomotic leakage, and
perfusion studies on stapled bowel specimens show that the
stapled anastomosis is at least as well vascularized as a hand-
sewn one. There may come a generation of adult surgeons
who are unable to do an intestinal anastomosis, although
paediatric surgeons have managed to preserve this technique
out of necessity because of the small size of their patients.
Poly-Anna (a pun on a well-known American
heroine of fiction)
It was recognized in the 1930s that certain animal cells could
thrive when explanted into a favourable environment in an-
other animal. An example of the successful use of this principle
came in 1975, when scientists encased pancreatic cells in a
semi-permeable membrane and placed them in the peritoneal
cavity of diabetics. They found that the cells secreted insulin
and the semi-permeable membrane protected them from
the body’s immune cells. With the work of John Burke and
others, major advances were made in the treatment of patients
with severe burns by explanting their skin cells into collagen
gels and growing them to produce large sheets of cells that
could be used as auto-generated skin grafts. These skin grafts,
however, are two-dimensional.
In the mid-1970s, Dr. Jay Vacanti spent 2 years in Dr. Judah
Folkman’s laboratory at the Boston Children’s Hospital where
he began, like all of Folkman’s protégés, to work on angio-
genesis. Here, Vacanti met Bob Langer, a chemical engineer
from the Massachusetts Institute of Technology (MIT), and
they concentrated on growing liver cells and trying to discover
ways to produce organelles. My own particular connection
to this story is that around the same time, I was working 1
day a week at the National Institutes of Health in Bethesda,
Maryland, trying to do the same thing. Although many of us
started in this area, most fell by the wayside, but Vacanti
persisted. After finishing his surgical residency and a paediat-
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ric surgical fellowship, Vacanti became responsible for start-
ing a liver transplant programme at Boston Children’s Hos-
pital. The main problem he encountered was the worldwide
shortage of organs and that children are always at the back
of the queue, behind adults. Vacanti reasoned that if three-
dimensional liver organelles could be grown, the liver short-
age could be alleviated. Langer, who in the meantime had had
his own distinguished career at MIT, continued with Vacanti
to develop three-dimensional polymers of polyglycolic acid
and polylactic acid to see whether: a three-dimensional biode-
gradable polymer could support cell growth; the cells would
align themselves into an organelle, i.e. liver cells, and would
line up in portal triads; arterial and venous intimal and medial
differentiation would occur from intimal cells; and smooth
muscle cells and the cell layers would naturally seek their
respective relationships. Theoretically, bladder epithelium and
muscle cells assume their normal relationships with each
other, cartilage incorporates to repair defects and engineered
small intestine can be functional. The polymers have been
modified in various chemical ways to alter the environment
and they have interstices through which nutritional factors
circulate. Once implanted, these cell constructs growing in
their biodegradable polymers attract blood vessels and be-
come well vascularized. Even when the polymers are absorbed,
the three-dimensional structure is retained and functions. It
was also shown that blood vessels look much more normal and
are stronger when the cells are grown in a pulsatile system and
subjected to the shear stress they will encounter in vivo. Histol-
ogy shows that the polymer has smooth muscle cells to the
outside and the intimal cells in their normal position lining
the blood vessel. The intima stains for Von Willebrand’s factor
and PECAM, the platelet endothelial cell adhesion mole-
cule, as in a normal artery. Arteries engineered from bovine
smooth muscle cells and endothelium can be implanted into
mini-pigs and function normally without clotting. Seeding of
prosthetic vascular grafts with autogenous endothelial cells is
also possible for human vascular bypass surgery.
There are dozens of possibilities for tissue engineering in
all areas of the body. There are clinical trials in several areas
such as bladder and heart. A parallel area of research in stem
cells has been adapted to develop normal tissue. Multiple
problems such as the vascularization of large complex organs
including liver and kidney still need to be solved, but the tissue
engineers are already experimenting with incorporation of
slow-release growth factors such as VEGF (vascular endothe-
lial growth factor) to stimulate the growth of larger and larger
vessels.
Eventually, engineered new parts for old will be as com-
mon and standard as joint replacement and transplantation
are today.
Beam me up Scottie
There is no better example of advances in medicine resulting
from cooperation between a physician and a scientist than ex-
emplified at Stanford by the association of Thomas Krummel
and Kenneth Salisbury. Ken Salisbury is an electrical and
mechanical engineer. He spent time at MIT developing tele-
operator systems and surgical simulation devices, particularly
with regard to haptic feedback. Tom Krummel, the Chairman
at Stanford, has been an innovator from the time of his sur-
gical residency at the Medical College of Virginia. There, he
single-handedly built and ran a long-term perfusion machine,
bringing extracorporeal membrane oxygenation to the treat-
ment of respiratory failure in newborns, and was second only
to Robert Bartlett at the University of Michigan, who pio-
neered the technique in newborns.
A great deal of the concept of cyber surgery came about
at the United States Uniformed Services Defense Advanced
Research Projects Agency (DARPA) in Arlington, Virginia. A
surgical genius at DARPA named Richard Satava, with great
imagination and flair, has not only helped develop the idea
of surgical simulation but also popularized it and helped to
get it accepted not only in the medical profession but also
among the public. Let me briefly highlight several areas in the
development of cyber surgery. Dr. Krummel has generously
provided me with a description of the Center for Advanced
Technology and Surgery at Stanford and I will paraphrase
several of the goals of this Center.
• We will use virtual reality to select, train, credential and re-
train physicians and surgeons.
• Surgeons will be able to rehearse an operation on a patient’s
specific palpable hologram and deliver the data set of that
operation with robotic assistance.
• We will use computer-aided virtual reality to improve surgi-
cal safety and extend the operating skill of surgeons.
Let me elaborate on the first goal, that of training, creden-
tialling and re-training. At medical school, most readers were
condemned to dissect the human body in a very uninteresting
way. It was filthy and smelly and students had to dissect pieces
of tissue of unknown origin and purpose. Imagine now a
simulated human body, a virtual man or woman in holo-
graph form, where one can literally walk around and through
the body, making the learning of anatomy exciting and relevant.
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The first simulator was a carnival ride developed by Edwin
Leek. In the aviation industry, advanced simulators are used to
train and re-train pilots and present them with virtually any
situation they are likely to encounter in a plane in real life.
Surgical simulators, first developed in the early 1990s, are
still crude and require a great deal of imagination to be useful.
The new generation of surgeons, however, is used to computer
games and has less difficulty with simulation than older sur-
geons who are used to handling the tissues directly and cannot
imagine a viable substitute for the “real thing”. Simulations
can be used for training in anatomy, trauma situations and
surgical procedures. For example, venous access, virtual en-
doscopy of any orifice, and suturing of blood vessels and other
tissue can be learned relatively easily.
In the second goal, surgeons can rehearse an operation by
combining holograms with CT and MRI scans. For example,
they can walk around a child with complex craniofacial
anomalies, an adult with an aortic aneurysm or patients with
brain tumours or vascular abnormalities. Like the aircraft
simulators, this will virtually eliminate the possibility of a
surprise. Real-time MRI with holograms of the brain in the
operating room will allow surgeons to adapt for shifts in brain
tissue that occur when the skull is opened. With the advent of
restricted working hours for residents, surgical teaching with
simulators will assume more and more importance.
My added goal is the use of computer-aided virtual reality
to improve surgical safety and extend the skills of surgeons.
What do I mean by this? For example, an ophthalmologist
working on the retina must operate within an area of accuracy
of 25 μm. The slightest jerk can produce a tear in the retina,
causing haemorrhage and subsequent blindness. Using a
platform-mounted camera, moving objects can be made to
appear stationary. Hand motions can be scaled down so that
a 1-cm movement of the hand becomes translated into 100
μm of actual movement of the instrument. A good friend of
mine who I frequently worked with is a plastic surgeon who
does microvascular flaps. He told me that his life as a micro-
vascular surgeon will probably not extend beyond the age of
45 years, because of unsteadiness or tremors of the hand that
increase with age. Here is a wonderful area for the computer-
ized scaling down of movement that would extend patient
safety and the operating life of surgeons.
Robotic surgery is taking off like laparoscopy did 15 years
ago. Every small hospital must have its CT scanner, MRI and
its robotic surgery units. What is the real value of robotic sur-
gery as opposed to the glitz and glamour of a new technique?
First, it will make laparoscopic surgery, which is awkward
and two-dimensional, three-dimensional. This will allow the
surgeon to use “real instruments” with full range of motion,
not awkward tools on a long stick. It will also help compensate
for the lack of haptic feedback. Second, robotic surgery truly
allows remote access to surgeons not just across the room
but across the country and across the world. We still have a
problem here. It takes 1.5 seconds, i.e. 1,500 ms, for a wireless
signal to reach and be reflected back from the communica-
tions satellites. Time lag is a problem for the human brain
when it goes above 200 ms. Nonetheless, people in remote
places can be trained or assisted by experts thousands of miles
away. Battlefield safety is an issue with pros and cons. Yes, it
would be safer to remotely operate on a battle casualty, at
least for the surgeon, but the con of this is that in the Mobile
Army Surgical Hospital (MASH), many more casualties can
be treated simultaneously once the injured soldier is removed
from the immediate danger of the battlefield. It remains to
be seen which technique will save the most lives. Third, the
educational value of computerized hands-on training is im-
measurable for medical students, residents and for trained
surgeons who need to re-educate themselves and learn new
techniques in surgery.
The ethical and practical issues raised by these new
developments are immense. What happens to that precious
surgeon-patient relationship? Do we develop a universal cre-
dentialling system countrywide and worldwide? Who devel-
ops the standards and who enforces them? What about Third
World countries who will not be able to afford these robots
in the near or intermediate future? Who will pay for all of this?
These problems are for young Nintendo surgeons to think
about and solve.
Sensory input
In the final section of my discussion of medical advances, I
come to something that is still in the future as far as clinical
medicine is concerned, but which is very exciting to me. Along
with my husband, Dr. French Anderson, and Dr. Robert
Bartlett, I am associated with a company that is developing
sensors to measure a number of analytes. At the moment, we
are working on oxygen, carbon dioxide and glucose sensors.
Skip Colvin is a physicist and chemist who started, in a bio-
technology company, to develop a sensor to measure oxygen
delivery to huge vats of bacterial cultures. Too much oxygen
and the bacteria would die of toxicity, too little would deprive
them of the ability to process the nutrients in the medium.
Why is this important? Science uses a vast volume of bacterial
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cultures for research. Colvin was lured away to start a company
to measure glucose for diabetes via an implantable sensor. The
sensor depends on a solute (e.g. glucose) altering the fluores-
cence of a molecule to generate an electric current that can
be “read” with a detector worn close to the implanted sensor.
The difficulty with most glucose sensors is that the analyte to
be measured must be chemically altered in order for a measure-
ment of concentration to be made. Colvin’s process does not
do this. The company is now working on miniaturizing this
sensor so that it can be implanted. It is the thickness of a very
short Chinese noodle, though we are working on an even
smaller unit, the size of a grain of rice. It seems to be tolerated
in a subcutaneous position and has been quite reliable both
from a biocompatibility point of view and also with regard to
being well enough encapsulated and vascularized that glu-
cose can be measured. The testing of the present sensor is pro-
gressing from the small animal stage to primates. The reader
is a modified wrist watch worn over the site of the implanted
sensor. It is showing great promise and accuracy in measuring
tissue glucose, which is analogous to blood glucose because
there is a very short lag time between a change in blood sugar
and the equivalent change in interstitial fluid glucose.
Ultimately, we will measure many body functions through
the use of implantable devices. Then, we will walk through a
scanner at our doctor’s office and have our body chemistry
available to us before the doctor ever sees us.
Is this a brave new world? Perhaps. But just as we finished
the last century of wonderful medical advances, so our young
surgeons, our children and grandchildren will look back and
be very glad to be alive in the 21st century.
